170 related articles for article (PubMed ID: 18390808)
21. Lead increases lipopolysaccharide-induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages: role of protein kinase C and P42/44 mitogen-activated protein kinase.
Cheng YJ; Yang BC; Liu MY
Environ Health Perspect; 2006 Apr; 114(4):507-13. PubMed ID: 16581537
[TBL] [Abstract][Full Text] [Related]
22. [The relationship between reactive oxygen species-dependent activation of p38 MAPK and the expression of tumor necrosis factor-α in cultured cardiomyocytes].
Shang FJ; Wang JP; Zheng QS; Liu XT; Xue YS; Li J; Zhao LY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):7-10. PubMed ID: 21208554
[TBL] [Abstract][Full Text] [Related]
23. Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis.
Haddad JJ; Land SC
Br J Pharmacol; 2002 Jan; 135(2):520-36. PubMed ID: 11815388
[TBL] [Abstract][Full Text] [Related]
24. α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.
Yu X; Jia B; Wang F; Lv X; Peng X; Wang Y; Li H; Wang Y; Lu D; Wang H
J Cell Mol Med; 2014 Feb; 18(2):263-73. PubMed ID: 24304472
[TBL] [Abstract][Full Text] [Related]
25. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
Tang ZY; Loss G; Carmody I; Cohen AJ
Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
[TBL] [Abstract][Full Text] [Related]
26. The involvement of L-gamma-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production.
Haddad JJ
Biochem Pharmacol; 2002 Jan; 63(2):305-20. PubMed ID: 11841806
[TBL] [Abstract][Full Text] [Related]
27. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin recognition in fish results in inflammatory cytokine secretion not gene expression.
Roher N; Callol A; Planas JV; Goetz FW; MacKenzie SA
Innate Immun; 2011 Feb; 17(1):16-28. PubMed ID: 20083499
[TBL] [Abstract][Full Text] [Related]
29. TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis.
Zhan M; Jin B; Chen SE; Reecy JM; Li YP
J Cell Sci; 2007 Feb; 120(Pt 4):692-701. PubMed ID: 17264149
[TBL] [Abstract][Full Text] [Related]
30. Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB.
Cao Q; Mak KM; Lieber CS
Biochem Biophys Res Commun; 2002 Jun; 294(4):849-53. PubMed ID: 12061785
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress is important in the pathogenesis of liver injury induced by sulindac and lipopolysaccharide cotreatment.
Zou W; Roth RA; Younis HS; Burgoon LD; Ganey PE
Toxicology; 2010 Jun; 272(1-3):32-8. PubMed ID: 20371263
[TBL] [Abstract][Full Text] [Related]
33. Sulindac metabolism and synergy with tumor necrosis factor-alpha in a drug-inflammation interaction model of idiosyncratic liver injury.
Zou W; Beggs KM; Sparkenbaugh EM; Jones AD; Younis HS; Roth RA; Ganey PE
J Pharmacol Exp Ther; 2009 Oct; 331(1):114-21. PubMed ID: 19638570
[TBL] [Abstract][Full Text] [Related]
34. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
[TBL] [Abstract][Full Text] [Related]
35. Hypertonicity-enhanced TNF-α release from activated human monocytic THP-1 cells requires ERK activation.
Chou YC; Sheu JR; Chung CL; Hsiao CJ; Hsueh PJ; Hsiao G
Biochim Biophys Acta; 2011 Apr; 1810(4):475-84. PubMed ID: 21256190
[TBL] [Abstract][Full Text] [Related]
36. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
37. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE
J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori-induced gastric mucosal TGF-α ectodomain shedding and EGFR transactivation involves Rac1/p38 MAPK-dependent TACE activation.
Slomiany BL; Slomiany A
Inflammopharmacology; 2016 Feb; 24(1):23-31. PubMed ID: 26658844
[TBL] [Abstract][Full Text] [Related]
39. Hypothemycin inhibits tumor necrosis factor-α production by tristetraprolin-dependent down-regulation of mRNA stability in lipopolysaccharide-stimulated macrophages.
Park KH; Yoon YD; Kang MR; Yun J; Oh SJ; Lee CW; Lee MY; Han SB; Kim Y; Kang JS
Int Immunopharmacol; 2015 Dec; 29(2):863-868. PubMed ID: 26371861
[TBL] [Abstract][Full Text] [Related]
40. Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK.
Sherry CL; O'Connor JC; Kramer JM; Freund GG
J Immunol; 2007 Jan; 178(2):663-70. PubMed ID: 17202326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
